Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
44 巻, 2 号
選択された号の論文の20件中1~20を表示しています
EDITORIALS
REVIEW ARTICLE
  • Hiroaki KAWANO, Hisao OGAWA
    2005 年 44 巻 2 号 p. 91-99
    発行日: 2005年
    公開日: 2005/03/05
    ジャーナル オープンアクセス
    Coronary spasm plays an important role in the pathogenesis of not only variant angina but also coronary heart disease in general including acute coronary syndromes, especially in the Japanese population. The vascular endothelium has been reported to be a multifunctional organ whose integrity is essential for normal vascular physiology. Vascular endothelial dysfunction can be a critical factor in the pathogenesis of ischemic heart disease. Acetylcholine and methacholine cause vasodilation by endothelium-derived relaxing factor when the endothelium is functioning normally, whereas they cause vasoconstriction when the endothelium is removed or damaged. Coronary spasm can be induced by a variety of stimuli with different mechanisms of action, including acetylcholine and methacholine. Patients with coronary spasm may have a disturbance in endothelial function as well as local hyperreactivity of the coronary arteries.
ORIGINAL ARTICLES
  • Masahiko KURE, Yoshiya KATSURA, Hiroshi KOSANO, Masayuki NORITAKE, Tos ...
    2005 年 44 巻 2 号 p. 100-106
    発行日: 2005年
    公開日: 2005/03/05
    ジャーナル オープンアクセス
    Objective To measure the amount and affinity of insulin antibodies, we performed a trial to establish a new method for quantitative and qualitative analysis of these antibodies by using surface plasmon resonance (BIAcoreTM system).
    Methods Real-time detection of insulin antibody interaction and kinetic analysis were performed using the BIAcoreTM system.
    Patients or Materials Eight diabetic patients with insulin antibodies and whose fasting total immunoreactive insulin levels were more than 100 μU/ml were selected. The patients with and without recurrent hypoglycemia were classified into hypoglycemic episode-positive or hypoglycemic episode-negative groups, respectively. Seven diabetic patients without insulin antibodies were selected as controls.
    Results In the 8 patients, the concentration of insulin antibodies ranged from 2.91 to 16.3 μg/ml and insulin antibodies were not detected in the control group. The apparent KD (dissociation constant) and kd (the dissociation rate constant) values of the patients were much larger than those seen for the anti-human insulin monoclonal antibody. The KD values were significantly higher in the hypoglycemic episode-positive group than in the hypoglycemic episode-negative group (p<0.05). No significant differences in the concentration, the ka (the association rate constant) and the kd values were noted between the groups.
    Conclusion The data suggests that insulin antibodies of the patients have an apparently lower affinity status in sera as compared with that for the anti-human insulin monoclonal antibody, and dissociate easily from the immune-complex in the sera, especially in cases where there is recurrent hypoglycemia in the patients. Therefore insulin antibody characteristics are one of the causative factors in hypoglycemic episodes.
  • Takashi HIROSE, Naoya HORICHI, Tohru OHMORI, Sohjiroh KUSUMOTO, Tomohi ...
    2005 年 44 巻 2 号 p. 107-113
    発行日: 2005年
    公開日: 2005/03/05
    ジャーナル オープンアクセス
    Objective To determine how Japanese patients with lung cancer weigh potential survival, chemotherapy response rate, and symptom relief against the potential toxicity of different treatments in cancer chemotherapy.
    Methods and Patients We used a questionnaire describing a hypothetical situation about stage IV non-small-cell lung cancer. Seventy-three patients with lung cancer who had received chemotherapy and 120 patients with other respiratory disease as the control group were asked to rate the minimal benefit that would make two hypothetical treatments acceptable. For “chance of cure,” “response but not cure,” and “symptom relief,” the subjects could give answers from 1% to 100% and for prolonging life could give answers from 1 to 60 months.
    Results Patients with lung cancer were significantly more likely than were patients with other respiratory diseases to accept either intensive or less-intensive treatments for a potentially small benefit for “chance of cure,” “response but not cure,” and “symptom relief”. The degree of survival advantage that patients require before accepting cancer treatment with its associated toxicity varied widely. If their lives were prolonged 3 months, 19% and 21% of patients with lung cancer would choose to receive intensive and less-intensive treatment, respectively. When the chance of symptom relief was 70%, 73% of patients with lung cancer were willing to choose intensive chemotherapy. Factor associated with patients’ choice of chemotherapy in both groups was age.
    Conclusion Oncologists must consider the substantial range of attitudes to chemotherapy among patients when making treatment decisions and they must give patients the opportunity to be included in this process.
CASE REPORTS
SHORT COMMUNICATION
PICTURES IN CLINICAL MEDICINE
LETTERS TO THE EDITOR
feedback
Top